Seroconversion rates following COVID-19 vaccination among patients with cancer

As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we determined a high seroconversion rate (94%) in 200 patients with cancer in New York City that had received full dosing with one of...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakkar, Astha, Gonzalez-Lugo, Jesus D., Goradia, Niyati, Gali, Radhika, Shapiro, Lauren C., Pradhan, Kith, Rahman, Shafia, Kim, So Yeon, Ko, Brian, Sica, R. Alejandro, Kornblum, Noah, Bachier-Rodriguez, Lizamarie, McCort, Margaret, Goel, Sanjay, Perez-Soler, Roman, Packer, Stuart, Sparano, Joseph, Gartrell, Benjamin, Makower, Della, Goldstein, Yitz D., Wolgast, Lucia, Verma, Amit, Halmos, Balazs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179248/
https://www.ncbi.nlm.nih.gov/pubmed/34133951
http://dx.doi.org/10.1016/j.ccell.2021.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179248/
https://www.ncbi.nlm.nih.gov/pubmed/34133951
http://dx.doi.org/10.1016/j.ccell.2021.06.002

Ejemplares similares